Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.22.9805

Radixin Knockdown by RNA Interference Suppresses Human Glioblastoma Cell Growth in Vitro and in Vivo  

Qin, Jun-Jie (Department of Neuropathology, Beijing Neurosurgical Institute)
Wang, Jun-Mei (Department of Neuropathology, Beijing Neurosurgical Institute)
Du, Jiang (Department of Neuropathology, Beijing Neurosurgical Institute)
Zeng, Chun (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors)
Han, Wu (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors)
Li, Zhi-Dong (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors)
Xie, Jian (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors)
Li, Gui-Lin (Department of Neuropathology, Beijing Neurosurgical Institute)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.22, 2014 , pp. 9805-9812 More about this Journal
Abstract
Radixin, a member of the ERM (ezrin-radixin-moesin) family, plays important roles in cell motility, invasion and tumor progression. It is expressed in a variety of normal and neoplastic cells, including many types of epithelial and lymphoid examples. However, its function in glioblastomas remains elusive. Thus, in this study, radixin gene expression was first examined in the glioblastoma cells, then suppressed with a lentivirus-mediated short-hairpin RNA (shRNA) method.We found that there were high levels of radixin expression in glioblastoma U251cells. Radixin shRNA caused down-regulation of radixin gene expression and when radixin-silenced cells were implanted into nude mice, tumor growth was significantly inhibited as compared to blank control cells or nonsense shRNA cells. In addition, microvessel density in the tumors was significantly reduced. Thrombospondin-1 (TSP-1) and E-cadherin were up-regulated in radixin- suppressed glioblastoma U251 cells. In contrast, MMP9 was down-regulated. Taken together, our findings suggest that radixin is involved in GBM cell migration and invasion, and implicate TSP-1, E-cadherin and MMP9 as metastasis-inducing factors.
Keywords
Malignant glioblastoma multiform; small interference RNA; radixin; thrombospondin-1;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Albini A, Iwamoto Y, Kleinman HK, et al (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45.
2 Berx G, Staes K, van Henqel J, et al (1995). Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics, 26, 281-9.   DOI   ScienceOn
3 Bretscher A, Edwards K, Fehon RG (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol, 3, 586-99.
4 Butler WB, Berlinski PJ, Hillman RM, et al (1986). Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res, 46, 6339-48.
5 Castle VP, Dixit VM, Polverini PJ (1997). Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells. Lab Invest, 77, 51-61.
6 Chen J, Xie F, Zhang L, et al (2010). iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer, 10, 694.   DOI
7 Chen SD, Song MM, Zhong ZQ, et al (2012). Knockdown of radixin by RNA interference suppresses the growth of human pancreatic cancer cells in vitro and in vivo. Asian Pac J Cancer Prev, 13, 753-9.   과학기술학회마을   DOI
8 Cheng CL, Johnson SP, Keir ST, et al (2005). Poly (ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol Cancer Ther, 4, 1364-8.   DOI
9 Curto M, McClatchey AI (2004). Ezrin a metastatic detERMinant? Cancer Cel, 5,113-4.   DOI
10 Darakhshan S, Bidmeshkipour A, Khazaei M, et al (2013). Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 Regulation in cultured human breast cancer cells. Asian Pac J Cancer Prev, 14, 6869-74.   과학기술학회마을   DOI   ScienceOn
11 Forsyth PA, Laing TD, Gibson AW, et al (1998). High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol, 36, 21-9.   DOI
12 Forsyth PA, Wong H, Laing TD, et al (1999). Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer, 79, 1828-35.   DOI
13 Frisch SM, Francis H (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 124, 619-26.   DOI   ScienceOn
14 Gautreau A, Louvard D, Arpin M (2002). ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol, 14, 104-9.   DOI
15 Geiger KD, Stoldt P, Schlote W, et al (2000). Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol, 157, 1785-93.   DOI   ScienceOn
16 Hoeflich KP, Tsukita S, Hicks L, et al (2003). Insights into a single rod-like helix in activated radixin required for membranecytoskeletal cross-linking. Biochemistry, 42, 11634-41.   DOI
17 Guo H, Ma Y, Zhang B, et al (2009). Pivotal advance: PKCzeta is required for migration of macrophages. J Leukoc Biol, 85, 911-8.   DOI
18 Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-64.   DOI   ScienceOn
19 Hoeflich KP, Ikura M (2004). Radixin: cytoskeletal adopter and signaling protein. Int J Biochem Cell Biol, 36, 2131-6.   DOI
20 Hoffman S, Propp JM, McCarthy BJ (2006). Temporal trends in incidence of primary brain tumors in the United States, 1985- 1999. Neuro Oncol, 8, 27-37.   DOI   ScienceOn
21 Jimenez B, Volpert OV, Crawford SE, et al (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med, 6, 41-8.   DOI   ScienceOn
22 Jin J, Cai L, Liu ZM, et al (2013). miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev, 14, 3681-4.   과학기술학회마을   DOI   ScienceOn
23 Khanna C, Wan X, Bose S, et al (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med, 10, 182-6.   DOI   ScienceOn
24 Kidoikhammouan S, Seubwai W, Tantapotinan N, et al (2013). TNP-470, A methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma Cells In Vitro. Asian Pac J Cancer Prev, 13, 155-60.
25 Liotta LA, Steeg PS, Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36.   DOI   ScienceOn
26 Kikuchi S, Hata M, Fukumoto K, et al (2002). Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Gene, 31, 320-5.   DOI
27 Kjaergaard J, Wang LX, Kuriyama H, et al (2005). Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines. J Neurosurg 103, 156-64.   DOI
28 Lawler J, Miao WM, Duquette M, et al (2001). Thrombospondin-1 gene expression affects survival and tumor spectrum of p53- deficient mice. Am J Pathol, 159, 1949-56.   DOI
29 McClatchey AI (2003). Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer, 3, 877-83.   DOI   ScienceOn
30 Meng Y, Lu Z, Yu S, et al (2010). Ezrin promotes invasion and metastasis of pancreatic cancer cells. J Transl Med, 8, 61.   DOI
31 Moon Y, Bottone FGJr, McEntee MF, et al (2005). Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol Cancer Ther, 4, 1551-8.   DOI   ScienceOn
32 Nakada M, Nakada S, Demuth T, et al (2007). Molecular targets of glioma invasion. Cell Mol Life Sci, 64, 458-78.   DOI   ScienceOn
33 Ng SS, Cheung YT, An XM, et al (2007). Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma. J Natl Cancer Inst, 99, 936-48.   DOI
34 Ramoni C, Luciani F, Spadaro F, et al (2002). Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. Eur J Immunol, 32, 3059-65.   DOI
35 Ou-Yang M, Liu H R, Zhang Y, et al (2011). ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. Biochimie, 93, 954-61.   DOI
36 Paglini G, Kunda P, Quiroga S, et al. (1998). Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. J Cell Biol, 143, 443-55.   DOI
37 Persson A, Lindwall C, Curtis MA, et al (2010). Expression of ezrin radixin moesin proteins in the adult subventricular zone and the rostral migratory stream. Neuroscience, 167, 312-22.   DOI
38 Revillion F, Lhotellier V, Hornez L, et al (2008). Real-time reversetranscription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion. Int J Biol Markers, 23, 10-7.
39 Schneider T, Mawrin C, Scherlach C, et al (2010). Gliomas in adults. Dtsch Arztebl Int, 107, 799-807.
40 Singh S, Sadanandam A, Varney ML, et al (2010). Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int J Cancer, 126, 328-36.   DOI
41 Stemmler MP (2008). Cadherins in development and cancer. Mol Biosyst, 4, 835-50.   DOI   ScienceOn
42 Stupp R, Hegi M E, van den Bent MJ, et al. (2006). Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist, 11, 165-80.   DOI
43 Tsukita S, Yonemura S (1999). Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem, 274, 34507-10.   DOI   ScienceOn
44 Suda J, Zhu L, Karvar S (2011). Phosphorylation of radixin regulates cell polarity and Mrp-2 distribution in hepatocytes. Am J Physiol Cell Physiol, 300, 416-24.   DOI
45 Sun XJ, Liu H, Zhang P, et al (2013). miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev, 14, 5533-7.   과학기술학회마을   DOI   ScienceOn
46 Takeichi M (1993). Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol, 5, 806-11.   DOI   ScienceOn
47 Turunen O, Wahlstrom T, Vaheri A (1994). Ezrin has a COOHterminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol, 126, 1445-53.   DOI   ScienceOn
48 Tynninen O, Carpen O, Jaaskelainen J, et al (2004). Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol, 30, 472-7.   DOI   ScienceOn
49 Uhm JH, Dooley NP, Villemure JG, et al (1997). Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurol Sci, 24, 3-15.
50 van Roy F and Berx G (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci, 65, 3756-88.   DOI   ScienceOn
51 Wen PY, Yung WK, Lamborn KR, et al (2006). Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res, 12, 4899-907.   DOI
52 Yahayo W, Supabpho A, Supabphol R (2013). Suppression of human fibrosarcoma cell metastasis by Phyllanthus emblica extract in Vitro. Asian Pac J Cancer Prev, 14, 6863-7.   과학기술학회마을   DOI   ScienceOn
53 Xia H, Qi Y, Ng SS, et al (2009). microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res, 1269, 158-65.   DOI